Chargement en cours...
Targeting Ornithine Decarboxylase for the Prevention of Nonmelanoma Skin Cancer in Humans
Bailey et al. report in this issue of the journal (beginning on page XXX) one of the first successful trials of basal cell carcinoma (BCC) prevention. Oral -difluoromethyl-dl-ornithine (DFMO) reduced new BCCs in patients with a prior history of non-melanoma skin cancer. DFMO is an inhibitor of ornit...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2926793/ https://ncbi.nlm.nih.gov/pubmed/20051367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-09-0248 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|